PNV-DHA

PNV-DHA- ascorbic acid, calcium, ferrous fumarate, cholecalciferol, .alpha.-tocopherol acetate, dl-, pyridoxine, folic acid and doconexent capsule, gelatin coated
Acella Pharmaceuticals, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Rx Only

DESCRIPTION

PNV-DHA + Docusate is a prescription prenatal/postnatal multivitamin/multimineral softgel with DHA. Each softgel is red in color and imprinted with “323” on one side.

† Daily Value (DV) not established.

SUPPLEMENT FACTS
Serving Size: 1 softgel
Amount Per Serving % Daily Value
Vitamin C (as ascorbic acid, USP) 28 mg 47%
Calcium (tribasic calcium phosphate, NF) 160 mg 16%
Iron (as ferrous fumarate, USP) 27 mg 150%
Vitamin D3 (as cholecalciferol, USP) 400 IU 100%
Vitamin E (as d-alpha-tocopherol acetate, USP) 30 IU 100%
Vitamin B6 (as pyridoxine HCl, USP) 25 mg 1250%
Folic Acid, USP 1.25 mg 313%
DHA (docosahexaenoic acid) 300 mg
Docusate sodium, USP 55 mg

OTHER INGREDIENTS

Bovine Gelatin, Glycerin, Soybean Oil, Soy Lecithin, Purified Water, Yellow Beeswax, FD&C Red # 40, Titanium Dioxide, Orange Cream Flavor, Ethyl Vanillin, FD&C Yellow # 6, and FD&C Blue #1. Contains soy.

INDICATIONS

PNV-DHA + Docusate is a multivitamin/mineral prescription dietary supplement indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers.

CONTRAINDICATIONS

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

WARNING

Ingestion of more than 3 grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.

PRECAUTIONS

Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.

ADVERSE REACTIONS

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

CAUTION: Exercise caution to ensure that the prescribed dosage of DHA does not exceed 1 grams (1000 mg) daily.

DOSAGE AND ADMINISTRATION

Usual adult dose is one (1) softgel daily or as directed by a physician.

KEEP OUT OF REACH OF CHILDREN.

HOW SUPPLIED

PNV-DHA + Docusate is supplied in child-resistant bottles of 30 softgels (42192-323-30). The listed product number is not a National Drug Code, but has merely been formatted to comply with standard industry practice for pharmacy and insurance computer systems.

Store at 20°- 25°C (68° — 77°F); excursions permitted to 15°- 30°C (59° — 86°F) [See USP, “Controlled Room Temperature”]. Protect from light and heat.

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

All prescription substitutions and/or recommendations using this product shall be made subject to state and federal statutes as applicable. Please note: This is not an Orange Book product and has not been subjected to FDA therapeutic equivalency or other equivalency testing. No representation is made as to generic status or bioequivalency. Each person recommending a prescription substitution using this product shall make such recommendations based on each such person’s professional opinion and knowledge, upon evaluating the dietary ingredients, other ingredients and information provided herein.

THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE.


MANUFACTURED FOR:
Acella Pharmaceuticals, LLC
Alpharetta, GA 30022
1-800-541-4802
Rev. 0717-01

PRINCIPAL DISPLAY PANEL — 30 Softgel Tablets

42192-323-30

PNV-DHA+Docusate

Rx Prenatal Vitamin and DHA
Dietary Supplement

Rx Only 30 Softgels

Acella PHARMACEUTICALS, LLC

PRINCIPAL DISPLAY PANEL -- Film Coated Tablets
(click image for full-size original)
PNV-DHA
ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, pyridoxine, folic acid, calcium, ferrous fumarate, doconexent capsule, gelatin coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42192-323
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ASCORBIC ACID (ASCORBIC ACID) ASCORBIC ACID 28 mg
CALCIUM (CALCIUM) CALCIUM 160 mg
FERROUS FUMARATE (FERROUS CATION) FERROUS CATION 27 mg
CHOLECALCIFEROL (CHOLECALCIFEROL) CHOLECALCIFEROL 400 [iU]
.ALPHA.-TOCOPHEROL ACETATE, DL- (.ALPHA.-TOCOPHEROL, DL-) .ALPHA.-TOCOPHEROL, DL- 30 [iU]
PYRIDOXINE (PYRIDOXINE) PYRIDOXINE 25 mg
FOLIC ACID (FOLIC ACID) FOLIC ACID 1.25 mg
DOCONEXENT (DOCONEXENT) DOCONEXENT 300 mg
Inactive Ingredients
Ingredient Name Strength
GELATIN TYPE B BOVINE (230 BLOOM)
GLYCERIN
SOYBEAN OIL
LECITHIN, SOYBEAN
WATER
YELLOW WAX
FD&C RED NO. 40
TITANIUM DIOXIDE
ORANGE
ETHYL VANILLIN
FD&C YELLOW NO. 6
FD&C BLUE NO. 1
Product Characteristics
Color RED Score no score
Shape CAPSULE Size 25mm
Flavor Imprint Code 323
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:42192-323-30 30 CAPSULE, GELATIN COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved drug other 10/01/2010
Labeler — Acella Pharmaceuticals, LLC (825380939)
Establishment
Name Address ID/FEI Operations
Acella Pharmaceuticals, LLC 825380939 manufacture (42192-323)

Revised: 09/2018 Acella Pharmaceuticals, LLC

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.